Abstract:Abstract Background Nutrient acquisition and metabolism pathways are altered in cancer cells to meet bioenergetic and biosynthetic demands. A major regulator of cellular metabolism and energy homeostasis, in normal and cancer cells, is AMP-activated protein kinase (AMPK). AMPK influences cell growth via its modulation of the mechanistic target of Rapamycin (mTOR) pathway, specifically, by inhibiting mTOR complex mTORC1, which facilitates cell proliferation, and by activating mTORC2 and cell survival. Given its conflicting roles, the effects of AMPK activation in cancer can be counter intuitive. Prior to the establishment of cancer, AMPK acts as a tumor suppressor. However, following the onset of cancer, AMPK has been shown to either suppress or promote cancer, depending on cell type or state. Methods To unravel the controversial roles of AMPK in cancer, we developed a computational model to simulate the effects of pharmacological maneuvers that target key metabolic signalling nodes, with a specific focus on AMPK, mTORC, and their modulators. Specifically, we constructed an ordinary differential equation-based mechanistic model of AMPK-mTORC signaling, and parametrized the model based on existing experimental data. Results Model simulations were conducted to yield the following predictions: (i) increasing AMPK activity has opposite effects on mTORC depending on the nutrient availability; (ii) indirect inhibition of AMPK activity through inhibition of sirtuin 1 (SIRT1) only has an effect on mTORC activity under conditions of low nutrient availability; (iii) the balance between cell proliferation and survival exhibits an intricate dependence on DEP domain-containing mTOR-interacting protein (DEPTOR) abundance and AMPK activity; (iv) simultaneous direct inhibition of mTORC2 and activation of AMPK is a potential strategy for suppressing both cell survival and proliferation. Conclusions Taken together, model simulations clarify the competing effects and the roles of key metabolic signalling pathways in tumorigenesis, which may yield insights on innovative therapeutic strategies.

AMPK and Cancer.

AMPK as a metabolic tumor suppressor: control of metabolism and cell growth

Targeting AMPK for cancer prevention and treatment.

AMPK: The energy sensor at the crossroads of aging and cancer

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy

AMP‐activated Protein Kinase Regulates Cancer Cell Growth and Metabolism Via Nuclear and Mitochondria Events

The mixed blessing of AMPK signaling in Cancer treatments

AMPK activation reduces cancer cell aggressiveness via inhibition of monoamine oxidase A (MAO-A) expression/activity

The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment

AMPK maintains TCA cycle through sequential phosphorylation of PDHA to promote tumor metastasis

Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells

Insights into the Role of mTOR/AMPK as a Potential Target for Anticancer Therapy

LKB 1 / AMPK / Mtor Signaling Pathway in Non-small-cell Lung Cancer

Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer

AMP-activated Protein Kinase α2 Protects against Liver Injury from Metastasized Tumors via Reduced Glucose Deprivation-induced Oxidative Stress

ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway

Energy Stress-activated AMPK Phosphorylates Snail1 and Suppresses Its Stability and Oncogenic Function

Epithelial–Mesenchymal Transition Suppresses AMPK and Sensitizes Cancer Cells to Pyroptosis under Energy Stress

AMPK signalling in health and disease

Phosphorylation of PDHA by AMPK Drives TCA Cycle to Promote Cancer Metastasis

Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism